Monthly Prescribing Reference

Evoke SCS System Approved for Chronic Intractable Pain

Evoke is a novel, closed-loop SCS system that instantaneously reads, records, and responds to evoked compound action potentials. The Food and Drug Administration (FDA) has approved the Evoke ® Spinal ...
Nasdaq

Abbott's (ABT) Eterna SCS System Receives FDA's Approval

Abbott Laboratories ABT recently received FDA approval for its Eterna spinal cord stimulation (SCS) system for treating chronic pain. The Eterna SCS system is the smallest implantable, rechargeable ...
Healio

Q&A: Spinal cord stimulation system offers nonopioid solution to pain management

Please provide your email address to receive an email when new articles are posted on . Spinal cord stimulation offers relief for patients who have not responded to other treatments for chronic ...
Business Wire

St. Jude Medical Announces FDA Approval of the Proclaim Elite SCS System, a Patient-Centric, Recharge-Free, Upgradeable and MR-conditional Chronic Pain Treatment Option

In particular, the non-rechargeable system improves patient convenience by removing the burden of regularly recharging the SCS system. The system’s upgradable platform allows patients to access future ...
Business Wire

St. Jude Medical Receives CE Mark Approval for Full Body MR Conditional Labeling for the Proclaim Elite Spinal Cord Stimulation System

New labeling ensures patients in need of future MRIs can have full access to the recharge-free Proclaim Elite SCS System and the company’s innovative BurstDR stimulation technology ST. PAUL, ...
Monthly Prescribing Reference

Abbott’s SCS System Cleared for Patients With Painful Diabetic Peripheral Neuropathy

It was originally approved in 2019 for the treatment of chronic pain. The Food and Drug Administration (FDA) has approved the Proclaim™ XR spinal cord stimulation (SCS) system for the treatment of ...
Yahoo Finance

First-of-its-Kind Study Shows Visibility into Real-Time Spinal Cord Stimulation Utilization and Supports a New Standard of Long-Term Device Management

Real-time insights reveal BIOTRONIK Neuro's remote monitoring with remote programming led to high rates of therapy use and lower explant rates LAKE OSWEGO, Ore., Jan. 5, 2026 /PRNewswire/ -- A new ...
Nasdaq

Nevro Announces U.S. Launch of Senza® Omnia(TM) Spinal Cord Stimulation System to Treat Chronic Pain

REDWOOD CITY, Calif., Nov. 5, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that provides innovative, evidence-based solutions for the treatment of chronic pain, today ...